MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

successful trial results for world-first obesity d, page-27

  1. 131 Posts.
    re: mike west - thanks i agree market makes no sen BUT what you are not aware of Mike, is that there is more news around the corner.
    They have stated that they are talking to multinational pharmaceutical companies with regards to Phase 3 trials (read the end of the last ann.) and that should bring the instituions in.
    It will be Roche, Pfizer, Glaxo or Merck.Roche probably want to be the monopoly with Xenical on the market, but my money would be on Pfizer or Glaxo.
    Then what?
    I want to be in before they announce a partner, not after.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.